NovaBay Pharmaceuticals Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
NovaBay Pharma (NBY) Reports Q3 Loss of $0.08/sh
November 12, 2020 4:34 PM ESTNovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.08), versus ($0.02) reported last year. Revenue for the quarter came in at $2.2 million, versus $1.62 million reported last year.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
... More